Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | KGX101 + unspecified PD-L1 antibody |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
KGX101 | KGX-101|KGX 101 | KGX101 is a prodrug comprising IL12 linked to an IL12RB-derived masking domain via a protease-sensitive linker that is cleaved by proteases in the tumor microenvironment, activating IL12 signaling and potentially stimulating an immune response and inhibiting tumor growth (Cancer Res (2024) 84 (6_Supplement): 4068). | ||
unspecified PD-L1 antibody | Experimental PD-L1 antibody | Immune Checkpoint Inhibitor 148 PD-L1/PD-1 antibody 119 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|